Tuesday, November 16, 2021: Life Sciences

Pfizer has agreed to a licensing deal with the U.N.’s Medicines Patent Pool for its COVID-19 pill. Under the agreement, Pfizer will manufacture and supply its effective antiviral pill in 95 countries, including all low-income and lower-middle-income nations. The...

Tuesday, November 16, 2021: Life Sciences

The Biden administration is withdrawing a Trump-era policy that limited the FDA’s review process of certain lab tests, including some COVID-19 tests. Under the policy, the agency did not require premarket reviews of laboratory-developed tests, even in situations...

Tuesday, November 16, 2021: Mental Health

The National Alliance on Mental Illness (NAMI) released a poll indicating that nearly 80 percent of Americans say mental health professionals, rather than law enforcement, should be the primary first responders to mental health crises. Seventy-two percent of...

Tuesday, November 16, 2021: Payers

Three labor organizations filed a petition indicating that they think the Biden administration’s COVID-19 vaccine mandate is too limited in applying to only large businesses. The AFL-CIO and the United Food and Commercial Workers International Union filed a petition...